Michelle J. West

2.1k total citations
41 papers, 1.7k citations indexed

About

Michelle J. West is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Michelle J. West has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Molecular Biology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Michelle J. West's work include Viral-associated cancers and disorders (19 papers), Lymphoma Diagnosis and Treatment (12 papers) and HIV Research and Treatment (9 papers). Michelle J. West is often cited by papers focused on Viral-associated cancers and disorders (19 papers), Lymphoma Diagnosis and Treatment (12 papers) and HIV Research and Treatment (9 papers). Michelle J. West collaborates with scholars based in United Kingdom, United States and Germany. Michelle J. West's co-authors include Jonathan Karn, Anne E. Willis, Helen Webb, Mark Stoneley, C. David Wood, Martin J. Allday, Cyril F. Bourgeois, Martin Rowe, Richard D. Palermo and Paul J. Farrell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The EMBO Journal.

In The Last Decade

Michelle J. West

40 papers receiving 1.7k citations

Peers

Countries citing papers authored by Michelle J. West

Since Specialization

Citations

This map shows the geographic impact of Michelle J. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle J. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle J. West more than expected).

Fields of papers citing papers by Michelle J. West

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle J. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle J. West. The network helps show where Michelle J. West may publish in the future.

Co-authorship network of co-authors of Michelle J. West

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle J. West. A scholar is included among the top collaborators of Michelle J. West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle J. West. Michelle J. West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repression of CADM1 transcription by HPV type 18 is mediated by three-dimensional rearrangement of promoter-enhancer interactions 2025 ·PLoS Pathogens ·(unknown), (unknown), Thomas Günther, C. David Wood, Steven Wingett, (unknown), (unknown), Lindsey Jones, Joanne Stockton, Csilla Várnai, Michelle J. West, Andrew D. Beggs, Adam Grundhoff, Boris Noyvert, Sally Roberts, Joanna L. Parish	2
2	Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4‐MYC oncogenic axis in multiple myeloma 2022 ·Hematological Oncology ·(unknown), Simon Mitchell, (unknown), C. David Wood, (unknown), Timothy Chevassut, Michelle J. West, Erika J. Mancini	5
3	The role of membrane-bound metal ions in toxicity of a human cancer cell-active pore-forming toxin Cry41Aa from Bacillus thuringiensis 2019 ·Toxicon ·(unknown), (unknown), Michelle J. West, Jean‐Louis Schwartz, Neil Crickmore	6
4	Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity 2019 ·PLoS Pathogens ·(unknown), Ritika Khatri, (unknown), C. David Wood, Erika J. Mancini, Paul J. Farrell, Michelle J. West	15
5	Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells 2018 ·Journal of Virology ·C. David Wood, (unknown), (unknown), (unknown), Cameron S. Osborne, Michelle J. West	40
6	Disruption of CTCF-YY1–dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription 2018 ·PLoS Biology ·(unknown), (unknown), Marius Cotic, (unknown), C. David Wood, Ian J. Groves, (unknown), Nicholas Coleman, Joanne Stockton, Boris Noyvert, Andrew D. Beggs, Michelle J. West, Sally Roberts, Joanna L. Parish	57
7	Chromatin reorganisation in Epstein-Barr virus-infected cells and its role in cancer development 2017 ·Current Opinion in Virology ·Michelle J. West	18
8	Roles of RUNX in B Cell Immortalisation 2017 ·Advances in experimental medicine and biology ·Michelle J. West, Paul J. Farrell	4
9	RUNXsuper-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth 2016 ·Nucleic Acids Research ·(unknown), Helen Webb, C. David Wood, (unknown), (unknown), Bettina Kempkes, Richard G. Jenner, Cameron S. Osborne, Paul J. Farrell, Michelle J. West	52
10	A Single Amino Acid in EBNA-2 Determines Superior B Lymphoblastoid Cell Line Growth Maintenance by Epstein-Barr Virus Type 1 EBNA-2 2014 ·Journal of Virology ·(unknown), (unknown), Claudio Elgueta Karstegl, (unknown), (unknown), (unknown), Michelle J. West, Paul J. Farrell	36
11	Modulation of Enhancer Looping and Differential Gene Targeting by Epstein-Barr Virus Transcription Factors Directs Cellular Reprogramming 2013 ·PLoS Pathogens ·(unknown), C. David Wood, (unknown), Tim J. Cooper, Aditi Kanhere, Aaron Arvey, Helen Webb, Richard D. Palermo, (unknown), Bettina Kempkes, Richard G. Jenner, Michelle J. West	73
12	RNA Polymerase II Stalling Promotes Nucleosome Occlusion and pTEFb Recruitment to Drive Immortalization by Epstein-Barr Virus 2011 ·PLoS Pathogens ·Richard D. Palermo, Helen Webb, Michelle J. West	46
13	Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells 2011 ·PLoS ONE ·(unknown), C. David Wood, (unknown), Helen Webb, (unknown), Aloys Schepers, Michelle J. West	22
14	Asymmetric Arginine dimethylation of Epstein–Barr virus nuclear antigen 2 promotes DNA targeting 2009 ·Virology ·(unknown), Stephanie Barth, Richard D. Palermo, (unknown), (unknown), Ursula Zimber‐Strobl, Michelle J. West, Elisabeth Kremmer, Friedrich A. Grässer	16
15	Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer 1999 ·The EMBO Journal ·Michelle J. West	24
16	Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway 1998 ·Oncogene ·Michelle J. West, Mark Stoneley, Anne E. Willis	156
17	Investigation of Aberrant Translational Control of c-myc in Cell Lines Derived from Patients with Multiple Myeloma 1997 ·Current topics in microbiology and immunology ·Anne E. Willis, F. Paulin, Michelle J. West, (unknown)	7
18	Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21 1997 ·Journal of Virology ·(unknown), Mark Bain, Paul J. Farrell, Michelle J. West, Martin Rowe, Martin J. Allday	87
19	A screen for photoirritants in cultured cells 1994 ·Toxicology in Vitro ·Manisha Dixit, Michelle J. West, L.K. Earl, W.W. Lovell	3
20	Simian Immunodeficiency Virus/Delta-Induced Immunodeficiency Disease in Rhesus Monkeys: Relation of Antibody Response and Antigenemia 1988 ·The Journal of Infectious Diseases ·(unknown), L N Martin, E. A. Watson, Ronald C. Montelaro, Michelle J. West, Leon G. Epstein, (unknown)	106

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact